Venrock Adviser, LLC
CIK 0001615982
Annualised vol
11.842343%
Beta
0.095393
HHI
1543.3485
Top-10 weight
80.388569%
VaR 95%
0.960948%
VaR 99%
2.354619%
Max drawdown
39.053483%
Matched value
59.473599%
Returns of reported holdings
Loading returns…
Position changes vs prior quarter
What the latest 13F shows bought and sold against the quarter before, by share count.
| Ticker | Change | Shares now | Shares before | Share change % | Value now ($) |
|---|---|---|---|---|---|
| ORKA | UNCHANGED | 4,148,428 | 4,148,428 | 0.0% | 394,805,893 |
| ERAS | ADDED | 17,891,812 | 16,382,812 | 9.21% | 327,777,996 |
| SYRE | REDUCED | 2,985,448 | 3,685,448 | -18.99% | 265,048,073 |
| OCUL | UNCHANGED | 10,346,926 | 10,346,926 | 0.0% | 101,606,813 |
| DMRA | UNCHANGED | 3,603,595 | 3,603,595 | 0.0% | 93,729,506 |
| SVRA | ADDED | 14,745,943 | 13,740,375 | 7.32% | 90,835,009 |
| JBIO | UNCHANGED | 3,220,364 | 3,220,364 | 0.0% | 71,556,488 |
| COGT | REDUCED | 1,642,166 | 2,000,000 | -17.89% | 63,551,824 |
| VOR | UNCHANGED | 3,041,719 | 3,041,719 | 0.0% | 55,998,047 |
| DYN | UNCHANGED | 2,173,913 | 2,173,913 | 0.0% | 48,282,608 |
| MAZE | UNCHANGED | 1,602,034 | 1,602,034 | 0.0% | 47,804,695 |
| RLMD | ADDED | 6,844,305 | 4,843,380 | 41.31% | 47,362,591 |
| ORIC | UNCHANGED | 4,319,765 | 4,319,765 | 0.0% | 46,783,055 |
| CBIO | UNCHANGED | 2,133,576 | 2,133,576 | 0.0% | 38,404,368 |
| ZURA | UNCHANGED | 6,434,990 | 6,434,990 | 0.0% | 37,966,441 |
| ANL | UNCHANGED | 3,212,731 | 3,212,731 | 0.0% | 36,946,407 |
| ELVN | REDUCED | 526,331 | 1,726,331 | -69.51% | 26,711,298 |
| HELP | UNCHANGED | 3,851,654 | 3,851,654 | 0.0% | 25,459,433 |
| CGEM | UNCHANGED | 1,379,965 | 1,379,965 | 0.0% | 25,129,163 |
| IPSC | UNCHANGED | 8,695,652 | 8,695,652 | 0.0% | 21,304,347 |
| ARTV | ADDED | 2,043,596 | 1,609,569 | 26.97% | 19,822,881 |
| CTMX | REDUCED | 4,982,124 | 9,982,124 | -50.09% | 18,682,965 |
| PBLS | NEW | 625,000 | - | - | 17,106,250 |
| KRRO | UNCHANGED | 1,009,500 | 1,009,500 | 0.0% | 13,305,210 |
| ANRO | UNCHANGED | 500,000 | 500,000 | 0.0% | 13,195,000 |
| XFOR | ADDED | 1,934,253 | 330,525 | 485.21% | 9,032,962 |
| RACC | NEW | 300,000 | - | - | 3,210,000 |
| INM | NEW | 32,685 | - | - | 50,662 |
| TENX | CLOSED OUT | 0 | 1,675,262 | -100.0% | 0 |
| SEPN | CLOSED OUT | 0 | 506,056 | -100.0% | 0 |
Holdings (latest quarter)
| Ticker | Change | Issuer | Class | CUSIP | Value ($) | Weight % | Shares |
|---|---|---|---|---|---|---|---|
| - | APOGEE THERAPEUTICS INC | COM | 03770N101 | 1,127,318,496 | 34.18 | 8493321.0 | |
| ORKA | UNCHANGED | ORUKA THERAPEUTICS INC | COM | 687604108 | 394,805,893 | 11.97 | 4148428.0 |
| ERAS | ADDED | ERASCA INC | COM | 29479A108 | 327,777,996 | 9.94 | 1.7891812E7 |
| SYRE | REDUCED | SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 265,048,073 | 8.04 | 2985448.0 |
| - | DIANTHUS THERAPEUTICS INC | COM | 252828108 | 115,026,400 | 3.49 | 1180000.0 | |
| OCUL | UNCHANGED | OCULAR THERAPEUTIX INC | COM | 67576A100 | 101,606,813 | 3.08 | 1.0346926E7 |
| DMRA | UNCHANGED | DAMORA THERAPEUTICS INC | COM NEW | 36322Q206 | 93,729,506 | 2.84 | 3603595.0 |
| SVRA | ADDED | SAVARA INC | COM | 805111101 | 90,835,009 | 2.75 | 1.4745943E7 |
| JBIO | UNCHANGED | JADE BIOSCIENCES INC | COM NEW | 008064206 | 71,556,488 | 2.17 | 3220364.0 |
| COGT | REDUCED | COGENT BIOSCIENCES INC | COM | 19240Q201 | 63,551,824 | 1.93 | 1642166.0 |
| - | VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 59,847,935 | 1.81 | 3257917.0 | |
| VOR | UNCHANGED | VOR BIOPHARMA INC | COM NEW | 929033207 | 55,998,047 | 1.7 | 3041719.0 |
| DYN | UNCHANGED | DYNE THERAPEUTICS INC | COM | 26818M108 | 48,282,608 | 1.46 | 2173913.0 |
| MAZE | UNCHANGED | MAZE THERAPEUTICS INC | COM | 578784100 | 47,804,695 | 1.45 | 1602034.0 |
| RLMD | ADDED | RELMADA THERAPEUTICS INC | COM | 75955J402 | 47,362,591 | 1.44 | 6844305.0 |
| ORIC | UNCHANGED | ORIC PHARMACEUTICALS INC | COM | 68622P109 | 46,783,055 | 1.42 | 4319765.0 |
| CBIO | UNCHANGED | CRESCENT BIOPHARMA INC. | COM | G2545C104 | 38,404,368 | 1.16 | 2133576.0 |
| ZURA | UNCHANGED | ZURA BIO LTD | CLASS A ORD SHS | G9TY5A101 | 37,966,441 | 1.15 | 6434990.0 |
| ANL | UNCHANGED | ADLAI NORTYE LTD | SPONSORED ADS | 00704R109 | 36,946,407 | 1.12 | 3212731.0 |
| ELVN | REDUCED | ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 26,711,298 | 0.81 | 526331.0 |
| HELP | UNCHANGED | CYBIN INC | COM NEW | 23256X407 | 25,459,433 | 0.77 | 3851654.0 |
| CGEM | UNCHANGED | CULLINAN THERAPEUTICS INC | COM | 230031106 | 25,129,163 | 0.76 | 1379965.0 |
| IPSC | UNCHANGED | CENTURY THERAPEUTICS INC | COM | 15673T100 | 21,304,347 | 0.65 | 8695652.0 |
| ARTV | ADDED | ARTIVA BIOTHERAPEUTICS INC | COM | 04317A107 | 19,822,881 | 0.6 | 2043596.0 |
| CTMX | REDUCED | CYTOMX THERAPEUTICS INC | COM | 23284F105 | 18,682,965 | 0.57 | 4982124.0 |
| - | ACHIEVE LIFE SCIENCE INC | COM | 004468500 | 17,964,239 | 0.54 | 2751032.0 | |
| PBLS | NEW | PARABILIS MEDICINES INC | COM | 698955101 | 17,106,250 | 0.52 | 625000.0 |
| - | SURROZEN INC | COM NEW | 86889P208 | 16,424,559 | 0.5 | 632931.0 | |
| KRRO | UNCHANGED | KORRO BIO INC | COM | 500946108 | 13,305,210 | 0.4 | 1009500.0 |
| ANRO | UNCHANGED | ALTO NEUROSCIENCE INC | COM SHS | 02157Q109 | 13,195,000 | 0.4 | 500000.0 |
| XFOR | ADDED | X4 PHARMACEUTICALS INC | COM NEW | 98420X202 | 9,032,962 | 0.27 | 1934253.0 |
| RACC | NEW | RESEARCH ALLIANCE CORP III | ORD SHS CL A | G75226103 | 3,210,000 | 0.1 | 300000.0 |
| INM | NEW | INMED PHARMACEUTICALS INC | COM NEW | 457637700 | 50,662 | 0.0 | 32685.0 |
Quarterly portfolios
| Period | Filed | Value ($) | Positions | Vol % | Beta | Max DD % |
|---|---|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | 3,298,051,614 | 33 | 11.842343 | 0.095393 | 39.053483 |
| 2026-03-31 | 2026-05-15 | 2,679,121,858 | 33 | 11.503567 | 0.097105 | 36.927931 |
| 2025-12-31 | 2026-02-17 | 2,024,517,832 | 27 | 8.745821 | 0.07721 | 30.573368 |
| 2025-09-30 | 2025-11-14 | 1,776,690,536 | 33 | 7.211966 | 0.062565 | 22.923615 |
| 2025-03-31 | 2025-05-15 | 1,175,247,364 | 37 | 6.953999 | 0.059487 | 21.885203 |
| 2024-12-31 | 2025-02-14 | 1,457,403,476 | 37 | 7.821354 | 0.067566 | 26.343533 |